Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-24-002571

Director bought 135,879 shares at an average $0.58 ($78,474)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Williamson Robert F III Director 2024-01-26 Purchase +12,250 $0.61 $7,473 87,926 D: show line 1 in the form
Williamson Robert F III Director 2024-01-26 Purchase +14,850 $0.61 $9,059 102,776 D: show line 2 in the form
Williamson Robert F III Director 2024-01-26 Purchase +8,513 $0.59 $5,023 111,289 D: show line 3 in the form
Williamson Robert F III Director 2024-01-26 Purchase +25,000 $0.55 $13,750 136,289 D: show line 4 in the form
Williamson Robert F III Director 2024-01-26 Purchase +50,000 $0.54 $27,000 186,289 D: show line 5 in the form
Williamson Robert F III Director 2024-01-29 Purchase +4,031 $0.64 $2,580 190,320 D: show line 6 in the form
Williamson Robert F III Director 2024-01-29 Purchase +21,235 $0.64 $13,590 211,555 D: show line 7 in the form
Open-market purchases · 135,879 sh · avg $0.58 · $78,474
Loading xslF345X05/rdgdoc.xml…